Enzymology of NAD+ homeostasis in man

Cellular and Molecular Life Sciences

Volumn 61, Issue 1, 2004, Pages 19-34

  Magni, G ^a   Amici, A ^a   Emanuelli, M ^a   Orsomando, G ^a   Raffaelli, N ^a   Ruggieri, S ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Chromatin expression; NAD+ homeostasis; Pyridine nucleotides; Recombinant enzymes; Structure biology

Indexed keywords

3 HYDROXYKYNURENINE; 5' NUCLEOTIDASE; ANTILEUKEMIC AGENT; ANTINEOPLASTIC AGENT; INORGANIC PYROPHOSPHATASE; KYNURENIC ACID; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE MONONUCLEOTIDE 5' NUCLEOTIDASE; NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE; NICOTINAMIDE RIBOSIDE; NICOTINAMIDE RIBOSIDE KINASE; NICOTINAMIDE RIBOSIDE PHOSPHORYLASE; PYRIDINE NUCLEOTIDE; TIAZOFURIN; UNCLASSIFIED DRUG;

CANCER RECURRENCE; CATALYSIS; CATALYST; CLINICAL TRIAL; ENZYME PURIFICATION; ENZYMOLOGY; HOMEOSTASIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; NUCLEOTIDE METABOLISM; OXIDATION REDUCTION REACTION; RECYCLING; REVIEW;

ENZYMES; HOMEOSTASIS; HUMANS; HYDROLASES; KINETICS; MODELS, BIOLOGICAL; NAD; NICOTINAMIDE-NUCLEOTIDE ADENYLYLTRANSFERASE; PROTEIN CONFORMATION;

EID: 1642458398     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-003-3161-1     Document Type: Review

References (175)

1. Ueda K. and Hayaishi O. (1985) ADP-ribosylation. Annu. Rev. Biochem. 54: 73-100
2. Germain M., Scovassi I. and Poirier G. G. (2000) Role of poly(ADP-ribose) polymerase in apoptosis. In: Cell Death: The Role of Poly(ADP-Ribose) Polymerase, pp. 209-225, Szabo C., CRC Press, Boca Raton, FL
3. Clapper D. L., Walseth T. F., Dargle P. J. and Lee H. C. (1987) Pyridine nucleotide metabolites stimulate calcium release from sea urchin egg microsomes desensitized to inositol triphosphate. J. Biol. Chem. 262: 9561-9568
4. Smith S., Giriat I., Schmitt A. and de Lange T. (1998) Tankyrase, a poly(ADP-ribose) polymerase at human telomeres. Science 282: 1484-1487
5. Griffith J. D., Comeau L., Rosenfield S., Stansel R. M., Bianchi A., Moss H. et al. (1999) Mammalian telomeres end in a large duplex loop. Cell 97: 503-514
6. Imai S. I., Armstrong C. M., Kaeberlein M. and Guarente L. (2001) Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403: 795-800
7. Vaziri H., Dessain S. K., Ng Eaton E., Imai S. I., Frye R. A., Pandita T. K. et al. (2001) hSIR2 (SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107: 149-159
8. Luo J., Nikolaev A. Y., Imai S., Chen D., Su F., Shiloh A. et al. (2001) Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 107: 137-148
9. Adams J. D., Klaidman L. K., Ghang M. L. and Yang J. (2001) Brain oxidative stress-analytical chemistry and thermodynamics of glutathione and NADPH. Curr. Top. Med. Chem. 1: 473-482
10. - synthesis. Adv. Enzymol. RAMB 73: 135-182
11. Bender D. A. (1982) Biochemistry of tryptophan in health and disease. Mol. Aspects Med. 6: 101-197
12. Heyes M. P., Chen C. Y., Major E. O. and Saito K. (1997) Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types. Biochem. J. 326: 351-356
13. Schwarcz R. (1993) Metabolism and function of brain kynurenines. Biochem. Soc. Trans. 21: 77-82
14. Heyes M. P. (1993) Metabolism and neuropathologic significance of quinolinic acid and kynurenic acid. Biochem. Soc. Trans. 21: 83-89
15. Moroni F. (1999) Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites. Eur. J. Pharmacol. 375: 87-100
16. Carlin J. M., Ozaki Y., Byne G. I., Brown R. R. and Borden E. C. (1989) Interferons and indoleamine 2,3-dioxygenase: role in antimicrobial and antitumor effects. Experientia 45: 535-541
17. Taylor M. W. and Feng G. S. (1991) Relationship between interferon-gamma, indoleamine 2,3-dioxygenase and tryptophan catabolism. FASEB J. 5: 2516-2522
18. Thomas S. R. and Stocker R. (1999) Redox reactions related to indoleamine 2,3-dioxygenase and tryptophan metabolism along the kynurenine pathway. Redox Rep. 4: 199-220
19. Yoshida R., Urade Y., Tokuda M. and Hayaishi O. (1979) Induction of indoleamine 2,3 dioxygenase in mouse lung during virus infection. Proc. Natl. Acad. Sci. USA 76: 4084-4086
20. Heyes M. P., Saito K., Jacobowitz D., Markey S. P., Takikawa O. and Vickers J. H. (1992) Polyovirus induces indoleamine 2,3-dioxygenase and quinolinic acid synthesis in macaque brain. FASEB J. 6: 2977-2989
21. Reinhard J. F. Jr (1998) Altered tryptophan metabolism in mice with herpes simplex virus encephalitis: increases in spinal cord quinolinic acid. Neurochem. Res. 23: 661-665
22. Yoshida R. and Hayaishi O. (1978) Induction of pulmonary indoleamine 2,3-dioxygenase by intraperitoneal injection of bacterial lipopolysaccharide. Proc. Natl. Acad. Sci. USA 75: 3998-4000
23. Takikawa O., Yoshida R., Kido R. and Hayaishi O. (1986) Tryptophan degradation in mice initiated by indoleamine 2,3-dioxygenase. J. Biol. Chem. 258: 3648-3653
24. Daubner W. and MacKenzie C. R. (1999) IFN-gamma activated indoleamine 2,3-dioxygenase activity in human cells is an antiparasitic and an antibacterial effector mechanism. Adv. Exp. Med. Biol. 467: 517-524
25. Sanni L. A., Thomas S. R., Tattam B. N., Moore D. E., Chaudhri G., Stocker R. et al. (1998) Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria. Am. J. Pathol. 152: 611-619
26. Burke F., Knowles R. G., East N. and Balkwill F. R. (1995) The role of indoleamine 2,3-dioxygenase in the antitumor activity of human interferon gamma in vivo. Int. J. Cancer 60: 115-122
27. Dias S., Thomas H. and Balkwill F. R. (1998) Multiple molecular and cellular changes associated with tumor stasis and regression during IL-2 therapy of a murine breast cancer model. Int. J. Cancer 75: 151-157
28. Yasui H., Takai K., Yoshida R. and Hayaishi O. (1986) Interferon enhances tryptophan metabolism by inducing pulmonary indoleamine 2,3 dioxygenase: its possible occurrence in cancer patients. Proc. Natl. Acad. Sci. USA 83: 6622-6626
29. Byrne G. I., Lehmann L. K. and Landry G. J. (1986) Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells. Infect. Immun. 53: 347-351
30. Takikawa O., Kuroiwa T., Yamazaki F. and Kido R. (1988) Mechanism of interferon-γ action. Characterization of indoleamine 2,3-dioxygenase in cultured human cells induced by interferon-γ and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity. J. Biol. Chem. 263: 2041-2048
31. Ozaki Y., Edelstein M. P. and Duch D. S. (1988) Induction of indolamine 2,3-dioxygenase: a mechanism of the antitumor activity of interferon-gamma. Proc. Natl. Acad. Sci. USA 85: 1242-1246
32. de la Maza L. M. and Peterson E. M. (1988) Dependence of the in vitro antiproliferative activity of recombinant human gamma-interferon on the concentration of tryptophan in culture media. Cancer Res. 48: 346-350
33. Frumento G., Rotondo R., Tonetti M., Damonte G., Benatti U. and Ferrara G. B. (2002) Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J. Exp. Med. 196: 459-468
34. Munn D. H., Shafizadeh E., Attwood J., Bondarev I., Pashine A. and Mellor A. (1999) Inhibition of T cell proliferation by macrophage tryptophan catabolism. J. Exp. Med. 189: 1363-1372
35. Hwu P., Du M. X., Lapointe R., Do M., Taylor M. W. and Young H. A. (2000) Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J. Immunol. 164: 3596-3599
36. Munn D. H., Zhou M., Attwood J. T., Bondarev I., Conway S. J., Marshall B. et al. (1998) Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281: 1191-1193
37. Logan G. J., Smith C. M., Earl J. W., Zaikina I., Rowe P. B., Smyhe J. A. et al. (2002) HeLa cells cocultured with peripheral blood lymphocytes acquire an immuno-inhibitory phenotype through up-regulation of indoleamine 2,3 dioxygenase activity. Immunology 105: 478-487
38. Fallarino F., Grohmann U., Vacca C., Bianchi R., Orabona C., Spreca A. et al. (2002) T cell apoptosis by tryptophan catabolism. Cell Death Differ. 9: 1069-1077
39. Lee G. K., Park H. J., Macleod M., Chandler P., Munn D. H. and Mellor A. L. (2002) Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division. Immunology 107: 452-460
40. Littlejohn T. K., Takikawa O., Skylas D., Jamie J. F., Walker M. J. and Truscott J. W. (2000) Expression and purification of recombinant human indoleamine 2,3-dioxigenase. Protein Expres. Purif. 19: 22-29
41. 2 into the reaction products. J. Biol. Chem. 252: 3548
42. Dai W. and Gupta S. L. (1990) Molecular cloning, sequencing and expression of human interferon-gamma-inducible indoleamine 2,3-dioxgenase cDNA. Biochem. Biophys. Res. Commun. 168: 1-8
43. Tone S., Takikawa O., Habara-Ohkubo A., Kadoya A., Yoshida R. and Kido R. (1990) Primary structure of human indoleamine 2,3-dioxygenase deduced from the nucleotide sequence of its cDNA. Nucleic Acids Res. 18: 367
44. Najfeld V., Menninger J., Muhleman D., Comings D. E. and Gupta S. L. (1993) Localization of indoleamine 2,3-dioxygenase gene (INDO) to chromosome 8p12 → p11 by fluorescent in situ hybridization. Cytogenet. Cell Genet. 64: 231-232
45. Tone S., Kadoya A., Maeda H., Minatogawa Y. and Kido R. (1994) Assignment of the human indoleamine 2,3-dioxygenase gene to chromosome 8 using the polymerase chain reaction. Hum. Genet. 93: 201-203
46. Maeda H., Tone S., Kadoya A., Iwamonoto Y., Minatogawa Y. and Kido R. (1992) Expression of human indoleamine 2,3-dioxygenase in E. coli. In: Advances in Tryptophan Research, pp. 417-420, (Ishiguro I., Kido R., Nagatsu T., Nagamura Y., Otha Y. (eds), Fujita Health University Press, Tokyo
47. Suzuki T. and Takagi T. A. (1992) Myoglobin evolved from indoleamine 2,3-dioxygenase. J. Mol. Biol. 228: 698-700
48. Suzuki T., Kawamichi H. and Imai K. (1998) Amino acid sequence, spectral, oxygen-binding and autoxidation properties of indoleamine dioxygenase-like myoglobin from the gastropod mollusc Turbo cornutus. J. Protein Chem. 17: 817-826
49. Terentis A. C., Thomas S. R., Takikawa O., Littlejohn T. K., Truscott R. J. W., Armstrong R. S. et al. (2002) The heme environment of recombinant human indoleamine 2,3-dioxygenase. J. Biol. Chem. 277: 15788-15794
50. Kadoja A., Tone S., Maeda H., Minotogawa Y. and Kido R. (1992) Gene structure of human indoleamine 2,3-dioxygenase. Biochem. Biophys. Res. Commun. 189: 530-536
51. Konan K. V. and Taylor M. W. (1996) Importance of two interferon-stimulated response element (ISRE) sequences in the regulation of the human indoleamine 2,3-dioxygenase. J. Biol. Chem. 271: 19140-19145
52. Comings D. E., Muhleman D., Dietz G. W. and Donlon T. (1991) Human tryptophan oxygenase localized to 4q31: possible implications for alcoholism and other behavioral disorders. Genomics 9: 301-308
53. Comings D. E., Muhlemann D., Dietz G., Sherman M. and Forest G. L. (1995) Sequence of human tryptophan 2,3-dioxygensae (TDO2): presence of a glucocorticoid response-like element composed of a GTT repeat and an intronic CCCCT repeat. Genomics 29: 390-396
54. Ren S., Liu H., Licad E., Correia M. A. (1996) Expression of rat liver tryptophan 2,3 dioxygenase in Escherichia coli: structural and functional characterization of the purified enzyme. Arch. Biochem. Biophys. 333: 96-102
55. Comings D. E., Gade R., Muhleman D., Chiu C., Wu S., To M. et al. (1996) Exon and intron variants in the human 2,3-dioxygenase gene: potential association with Tourette syndrome, substance abuse and other disorders. Pharmacogenetics 6: 307-318
56. Vasiliev G. V., Merkulov V. M., Kobzev V. F., Merkulova T. I., Ponomarenko M. P. and Kolchanov N. A. (1999) Point mutations within 663-666 bp of intron 6 of the human TDO2 gene, associated with a number of psychiatric disorders, damage the YY-1 transcription factor binding site. FEBS Lett. 462: 85-88
57. Pabarcus M. K. and Casida J. E. (2002) Kynurenine formamidase: determination of primary structure and modeling-based prediction of tertiary structure and catalytic triad. Biochim. Biophys. Acta 1596: 201-211
58. Alberati-Giani D., Cesura A. M., Broger C., Warren W. D., Rover S. and Malerbe P. (1997) Cloning and functional expression of human kynurenine 3-monooxygenase. FEBS Lett. 410: 407-412
59. Guillemin G. J., Kerr S. J., Smythe G. A., Smith D. G., Kapoor V., Armati P. J. et al. (2001) Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection. J. Neurochem. 78: 842-853
60. Heyes M. P., Achim C. L., Wiley C. A., Major E. O., Saito K. and Markey S. P. (1996) Human microglia convert L-tryptophan into the neurotoxin quinolinic acid. Biochem J. 320: 595-597
61. Chiarugi A., Calvani M., Meli E., Traggiai E. and Moroni F. (2001) Synthesis and release of neurotoxic kynurenine metabolites by human monocyte-derived macrophages. J. Neuroimmunol. 120: 190-198
62. Okuda S., Nishiyama N., Saito H. and Katsuki H. (1996) Hydrogen peroxide-mediated neuronal cell death induced by endogenous neurotoxin, 3-hydroxykynurenine. Proc. Natl. Acad. Sci. USA 93: 12553-12558
63. Okuda S., Nishiyama N., Saito H. and Katsuki H. (1998) 3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity. J. Neurochem. 70: 299-307
64. Stone T. W. (1993) Neuropharmacology of quinolinic and kynurenic acids. Pharmacol. Rev. 45: 309-379
65. Breton J., Avanzi N., Magagnin S., Covini N., Magistrelli G., Cozzi L. et al. (2000) Functional characterization and mechanism of action of recombinant human kynurenine 3-hydroxylase. Eur. J. Biochem. 267: 1092-1099
66. Cozzi A., Carpenedo R. and Moroni F. (1999) Kynurenine hydroxylase inhibitors reduce ischemic brain damage: studies with (m-nitro-benzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(nitrophenyl)thiazol-2yl]-benzensulfonamide (Ro 61-8048) in models of focal or global brain ischemia. J. Cereb. Blood F. Met. 19: 771-777
67. Halford S., Freedman M. S., Bellingham J., Inglis S. L., Poopalasundar S., Soni B. G. et al. (2001) Characterization of a novel human opsin gene with wide tissue expression and identification of embedded and flanking genes on chromosome 1q43. Genomics 72: 203-208
68. van de Kamp J. L. and Smolen A. (1995) Response of kynurenine pathway enzymes to pregnancy and dietary level of vitamin B-6. Pharmacol. Biochem. Behav. 51: 753-758
69. Ubbink J. B., Vermaak W. J. and Bissbort S. H. (1991) High-performance liquid chromatographic assay of human lymphocyte kynureninase activity levels. J. Chromatogr. 566: 369-375
70. Alberati-Giani D., Buchli R., Malherbe P., Broger C., Lang G., Kohler C. et al. (1996) Isolation and expression of a cDNA clone encoding human kynureninase. Eur. J. Biochem. 239: 460-468
71. Toma S., Nakamura M., Toné S., Okuno E., Kido R., Breton J. et al. (1997) Cloning and recombinant expression of rat and human kynureninase. FEBS Lett. 408: 5-10
72. Walsh H. A. and Botting N. P. (2002) Purification and biochemical characterization of some of the properties of recombinant human kynureninase. Eur. J. Biochem. 269: 2069-2074
73. Fitzgerald D. H., Muirhead K. M. and Botting N. P. (2001) A comparative study on the inhibition of human and bacterial kynureninase by novel bicyclic kynurenine analogues. Bioorg. Med. Chem. 9: 983-989
74. Walsh H. A., Leslie P. L., O'Shea K. C. and Botting N. P. (2002) 2-Amino-4-[3′-hydroxyphenyl]-4-hydroxybutanoic acid; a potent inhibitor of rat and recombinant human kynureninase. Bioorg. Med. Chem. Lett. 12: 361-363
75. 2+. Biochim. Biophys. Acta 1596: 283-292
76. Malherbe P., Kohler C., Da Prada M., Lang G., Kiefer V., Schwarcz R. et al. (1994) Molecular cloning and functional expression of human 3-hydroxyanthranilic-acid dioxygenase. J. Biol. Chem. 269: 13792-13797
77. Shin-ichi F., Kanako I., Kazumi Y., Atsushi T., Yukari E., Egashira Y. et al. (2002) Identification and expression of a cDNA encoding human α-amino-β-carboxymuconate-ε-semialdehyde decarboxylase (ACMSD). J. Biol. Chem. 277: 35162-35167
78. Okuno E., White R. J. and Schwarcz R. (1988) Quinolinic acid phosphoribosyltransferase: purification and partial characterization from human liver and brain. J. Biochem. 103: 1054-1059
79. Du F., Okuno E., Whetsell W. O. Jr, Kohler C. and Schwarcz R. (1990) Distribution of quinolinic acid phosphoribosyltransferase in the human hippocampal formation and parahippocampal gyrus. J. Comp. Neurol. 295: 71-82
80. Feldblum S., Rougier A., Loiseau H., Loiseau P., Cohadon F., Morselli P. L. et al. (1988) Quinolinic-phosphoribosyl transferase activity is decreased in epileptic human brain tissue. Epilepsia 29: 523-529
81. Stone T. W. and Perkins M. N. (1981) Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS. Eur. J. Pharmacol. 72: 411-412
82. Foster A. C., Vhetsell W. O., Bird E. D. and Schwarcz R. (1985) Quinolinic acid phosphoribosyltransferase in human and rat brain: activity in Huntington disease and in quinolinate-lesioned rat striatum. Brain Res. 336: 207-214
83. Heyes M. P., Saito K., Crowley J. S., Davis L. E., Demitrack M. A., Der M. et al. (1992) Quinolinic acid and kynurenine pathway metabolism in inflammatory and noninflammatory neurological disease. Brain 115: 1249-1273
84. Foster A. C. and Schwarcz R. (1985) Characterization of quinolinic acid phosphoribosyltransferase in human blood and observations in Huntington disease. J. Neurochem. 45: 199-205
85. Shibata K. and Iwai K. (1980) Isolation and properties of crystalline quinolinate phosphoribosyltransferase from hog kidney. Biochim. Biophys. Acta 611: 280-288
86. Cao H., Pietrak B. L. and Grubmeyer C. (2002) Quinolinate phosphoribosyltransferase: kinetic mechanism for a type II PRTase. Biochemistry 41: 3520-3528
87. Bhatia R. and Calvo K. C. (1996) The sequencing expression, purification and steady-state kinetic analysis of quinolinate phosphoribosyl transferase from Escherichia coli. Arch. Biochem. Biophys. 325: 270-278
88. Eads J. C., Ozturk D., Wexler T. B., Grubmeyer C. and Sacchettini J. C. (1997) A new function for a common fold: the crystal structure of quinolinic acid phosphoribosyltransferase. Structure 5: 47-58
89. Kalikin L. and Calvo K. C. (1988) Inhibition of quinolinate phosphoribosyl transferase by pyridine analogs of quinolinic acid. Biochem. Biophys. Res. Commun. 152: 559-564
90. Fukuoka S. I., Nyaruhucha C. M. and Shibata K. (1998) Characterization and functional expression of the cDNA encoding human brain quinolinate phosphoribosyltransferase. Biochim. Biophys. Acta 1395: 192-201
91. Kornberg A. (1948) The participation of inorganic pyrophosphate in the reversible enzymatic synthesis of diphosphopyridine nucleotide. J. Biol. Chem. 176: 1475-1476
92. Raffaelli N., Sorci L., Amici A., Emanuelli M., Mazzola F. and Magni G. (2002) Identification of a novel human nicotinamide mononucleotide adenylyltransferase. Biochem. Biophys. Res. Commun. 297: 835-840
93. Zhang X., Kurnasov O. V., Karthikeyan S., Grishin N. V., Osterman A. L. and Zhang H. (2003) Structural characterization of a human cytosolic NMN/NaMN adenylyltransferase and implication in human NAD biosynthesis. J. Biol. Chem. 278: 13503-13511
94. Emanuelli M., Natalini P., Raffaelli N., Ruggieri S., Vita A. and Magni G. (1992) NAD biosynthesis in human placenta: purification and characterization of homogeneous NMN adenylyltransferase. Arch. Biochem. Biophys. 298: 29-34
95. Emanuelli M., Carnevali F., Saccucci F., Pierella F., Amici A., Raffaelli N. et al. (2001) Molecular cloning, chromosomal localization, tissue mRNA levels, bacterial expression and enzymatic properties of human NMN adenylyltransferase. J. Biol. Chem. 276: 406-412
96. Schweiger M., Hennig K., Lerner F., Niere M., Hirsch-Kauffmann M., Specht T. et al. (2001) Characterization of recombinant human nicotinamide mononucleotide adenylyl transferase (NMNAT), a nuclear enzyme essential for NAD synthesis. FEBS Lett. 492: 95-100
97. Ruggieri S. and Magni G. (1982) Isolation of yeast nuclei. Evidence of chromatin-associated proteolytic activity. Physiol. Chem. Phys. 14: 315-321
98. Balducci E., Emanuelli M., Magni G., Raffaelli N., Ruggieri S., Vita A. et al. (1992) Nuclear matrix-associated NMN adenylyltransferase activity in human placenta. Biochem. Biophys. Res. Commun. 189: 1275-1279
99. Uhr M. L. and Smulson M. (1982) NMN adenylyltransferase: its association with chromatin and with poly(ADP-ribose) polymerase. Eur. J. Biochem. 128: 435-443
100. Ruggieri S., Gregori L., Natalini P., Vita A., Emanuelli M., Raffaelli N. et al. (1990) Evidence for an inhibitory effect exerted by yeast NMN adenylyltransferase on poly(ADP-ribose)polymerase activity. Biochemistry 29: 2501-2506
101. Garavaglia S., D'Angelo I., Emanuelli M., Carnevali F., Pierella F., Magni G. et al. (2002) Structure of human NMN adenylyltransferase. A key nuclear enzyme for NAD homeostasis. J. Biol. Chem. 277: 8524-8530
102. Raffaelli N., Pisani F. M., Lorenzi T., Emanuelli M., Amici A., Ruggieri S. et al. (1997) Characterization of nicotinamide mononucleotide adenylyltransferase from thermophilic archaea. J. Bacteriol. 179: 7718-7723
103. Emanuelli M., Carnevali F., Lorenzi M., Raffaelli N., Amici A., Ruggieri S. et al. (1999) Identification and characterization of YLR328W, the Saccharomyces cerevisiae structural gene encoding NMN adenylyltransferase. Expression and characterization of the recombinant enzyme. FEBS Lett. 445: 13-17
104. Emanuelli M., Amici A., Carnevali F., Pierella F., Raffaelli N. and Magni G. (2003) Identification and characterization of a second NMN adenylyltransferase gene in Saccharomyces cerevisiae. Protein Expr. Purif. 27: 357-364
105. Lowe G. and Tansley G. (1983) The stereochemical course of nucleotidyl transfer catalyzed by NAD pyrophosphorylase. Eur. J. Biochem. 132: 117-120
106. Kornberg A. (1950) Reversible enzymatic synthesis of diphosphopyridine nucleotide and inorganic pyrophosphate. J. Biol. Chem. 182: 779-793
107. Balducci E., Orsomando G., Polzonetti V., Vita A., Emanuelli M., Raffaelli N. et al. (1995) NMN adenylyltransferase from bull testis: purification and properties. Biochem. J. 310: 395-400
108. Jayaram H. N., Pillwein K., Lui M. S., Faderan M. A. and Weber G. (1986) Mechanism of resistance to tiazofurin in hepatoma 3924A. Biochem. Pharmacol. 35: 587-593
109. Boulton S., Kyle S. and Durkacz B. W. (1997) Low nicotinamide mononucleotide adenylyltransferase activity in a tiazofurin-resistant cell line: effects on NAD metabolism and DNA repair. Br. J. Cancer. 76: 845-851
110. Jager W., Salamon A. and Szekeres T. (2002) Metabolism of the novel IMP dehydrogenase inhibitor benzamide riboside. Curr. Med. Chem. 9: 781-786
111. Shama Fernando F., Conforti L., Tosi S., Smith A. D. and Coleman M. P. (2002) Human homologue of a gene mutated in the slow Wallerian degeneration (C57BL/Wlds) mouse. Gene 284: 23-29
112. Morton R. K. (1958) Enzymic synthesis of coenzyme I in relation to chemical control of cell growth. Nature 181: 540-542
113. Emanuelli M., Raffaelli N., Amici A., Balducci E., Natalini P., Ruggieri S. et al. (1995) The antitumor drug, 1,3-bis(2-chloroethyl)-1-nitroso-urea, inactivates human nicotinamide mononucleotide adenylyltransferase. Biochem. Pharmacol. 49: 575-579
114. Mack T. G., Reiner M., Beirowski B., Mi W., Emanuelli M., Wagner D. et al. (2001) Wallerian degeneration of injured axons and synapses is delayed by Ube4b/Nmnat chimeric gene. Nat. Neurosci. 4: 1199-206
115. Werner E., Ziegler M., Lerner F., Schweiger M. and Heinemann U. (2002) Crystal structure of human nicotinamide mononucleotide adenylyltransferase in complex with NMN. FEBS Lett. 516: 239-244
116. Zhou T., Kurnasov O., Tomchick D. R., Binns D. D., Grishin N. V., Marquez V. E. et al. (2002) Structure of human nicotinamide/nicotinic acid mononucleotide adenylyltransferase. Basis for the dual substrate specificity and activation of the oncolytic agent tiazofurin. J. Biol. Chem. 277: 13148-13154
117. Gerdes S. Y., Scholle M. D., D'Souza M., Bernal A., Baev M. V., Farrel M. et al. (2002) From genetic footprinting to antimicrobial drug targets: examples in cofactor biosynthetic pathways. J. Bacteriol. 184: 4555-4572
118. Sood R., Bonner T. I., Makalowska I., Stephan D. A., Robbins C. M., Connors T. D. et al. (2001) Cloning and characterization of 13 novel transcripts and the human RGS8 gene from the 1q25 region encompassing the hereditary prostate cancer (HPC1) locus. Genomics 73: 211-222
119. Yu C. K. and Dietrich L. S. (1972) Purification and properties of yeast nicotinamide adenine dinucleotide synthetase. J. Biol. Chem. 247: 4794-4802
120. Zerez C. R., Wong M. D. and Tanaka K. R. (1990) Partial purification and properties of nicotinamide adenine dinucleotide synthetase from human erythrocytes: evidence that enzyme activity is a sensitive indicator of lead exposure. Blood 75: 1576-1582
121. Nessi C., Albertini A. M., Speranza M. L. and Galizzi A. (1995) The outB gene of Bacillus subtilis codes for NAD synthetase. J. Biol. Chem. 270: 6181-6185
122. Hara N., Yamada K., Terashima M., Osago H., Shimoyama M. and Tsuchiya M. (2003) Molecular identification of human glutamine- and ammonia-dependent NAD synthetases. J. Biol. Chem. 278: 10914-10921
123. + synthetase from Bacillus subtilis. EMBO J. 15: 5125-5134
124. Tesmer J. G., Klem T. J., Deras M. L., Davisson, V. J. and Smith J. (1996) The crystal structure of GMP synthetase reveals a novel catalytic triad and is a structural paradigm for two enzyme families. Nat. Struct. Biol. 3: 74-86
125. - synthetase. J. Bacteriol. 180: 3218-3221
126. Bellinzoni M., De Rossi E., Branzoni M., Milano A., Peverali F. A., Rizzi M. and Riccardi G. (2002) Heterologous expression, purification and enzymatic activity of Mycobacterium tuberculosis NAD synthetase. Protein Expr. Purif. 25: 547-557
127. Lerner F., Niere M., Ludwig A. and Ziegler M. (2001) Structural and functional characterization of human NAD kinase. Biochem. Biophys. Res. Commun. 288: 69-74
128. Lee H. C. (2002) Cyclic ADP-Ribose and NAADP-Structure Metabolism and Function, Kluwer Academic Publisher, Boston
129. Smith S. (2001) The world according to PARP. Trends Biochem. Sci. 26: 174-179
130. Lee H. C. (2001) Physiological function of cyclic ADP-ribose and NAADP as calcium messengers. Annu. Rev. Pharmacol. Toxicol. 41: 317-345
131. +-dependent deacetylases. Trends Biochem. Sci. 28: 41-48
132. Rechsteiner M. and Catanzarite V. (1974) Biosynthesis and turnover of nicotinamide adenine dinucleotide in enucleated culture cells. J. Cell Physiol. 84: 409-422
133. Magni G., Raffaelli N., Emanuelli M., Amici A., Natalini P. and Ruggieri S. (1997) Nicotinamide-mononucleotide adenylyltransferases from yeast and other microorganisms. Methods Enzymol. 280: 248-254
134. Shieh M., Amé J. C., Wilson M. W., Wang Z. K., Koh D. W., Jacobson M. K. et al. (1998) Poly(ADP-ribose) polymerase null mouse cells synthesize ADP-ribose polymers. J. Biol. Chem. 273: 30069-30072
135. Smith S. and de Lange T. (2000) Tankyrase, promotes telomere elongation in human cells. Curr. Biol. 10: 1299-1302
136. Rippmann J. F., Damm K. and Schnapp A. (2002) Functional characterization of the poly(ADP-ribose) polymerase activity of tankyrase 1, a potential regulator of telomere length. J. Mol. Biol. 323: 217-224
137. Lyons R. J., Deane R., Lynch D. K., Ye Z. S., Sanderson G. and Eyre H. J. (2001) Identification of a novel human tankyrase through its interaction with the adaptor protein Grb14. J. Biol. Chem. 276: 17172-17180
138. Johansson M. (1999) A human poly(ADP-ribose) polymerase gene family (ADPRTL): cDNA cloning of two novel poly(ADP-ribose) polymerase homologues. Genomics 57: 442-445
139. Kichhoefer V. A., Siva A. C., Kedersha N. L., Inman E. M., Ruland C., Streuli M. et al. (1999) The 193-kD vault protein is a novel poly(ADP-ribose) polymerase. J. Cell Biol. 146: 917-928
140. Okazaki I. J. and Moss J. (1996) Structure and function of eukaryotic mono-ADP-ribosyltransferases. In: Reviews of Physiology, Biochemistry and Pharmacology, pp. 51-103, Blauenstein M. P. and Grunicke H. (eds), Springer-Verlag, New York
141. Han S. and Tainer J. A. (2002) The ARTT motif and a unified structural understanding of substrate recognition in ADP-ribosylating bacterial toxins and eukaryotic ADP-ribosyltransferases. Int. J. Med. Microbiol. 291: 523-529
142. Grahnert A., Friedrich M., Pfister M., Haag F., Koch-Nolte F. and Hauschildt S. (2002) Mono-ADP-ribosyltransferases in human monocytes: regulation by lipopolysaccharide. Biochem. J. 362: 717-723
143. Malavasi F., Funaro A., Roggero S., Horenstein A. Colosso L. and Mehta K. (1994) Human CD38: a glycoprotein in search of a function. Immunol. Today 15: 95-97
144. Graeff R., Munshi C., Aarhus R., Johns M. and Lee H. C. (2001) A single residue at the active site of CD38 determines its NAD cyclizing and hydrolyzing activities. J. Biol. Chem. 276: 12169-12173
145. Okamoto H. and Takasawa S. (2002) The CD38-cyclic ADP-ribose signal system and the regenerating gene protein (Reg)-Reg receptor system in beta-cells. Diabetes 51: S462-S473
146. Frye R. A. (2000) Phylogenetic classification of prokaryotic and eukaryotic SIR2-like proteins. Biochem. Biophys. Res. Commun. 273: 793-798
147. +-dependent histone/protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose. Proc. Natl. Acad. Sci. USA 97: 14178-14182
148. + breakdown product. Proc. Natl. Acad. Sci. USA 98: 415-420
149. +-dependent deacetylation reactions. Biochemistry 40: 15456-15463
150. +-dependent histone/protein deacetylases. J. Biol. Chem. 277: 18535-18544
151. +-dependent deacetylases. J. Biol. Chem. 277: 12632-12641
152. Schwer B., North B. J., Frye R. A., Ott M. and Verdin E. (2002) The human silent information regulator (Sir)2 homologue is a mitochondrial nicotinamide adenine dinucleotide-dependent deacetylase. J. Cell Biol. 158: 647-657
153. Gale E. A. (2003) Intervening before the onset of type 1 diabetes: baseline data from the European Nicotinamide Diabetes Intervention Trial (ENDIT). Diabetologia 46: 339-346
154. Kaanders J. H., Bussink J. and Van der Kogel A. J. (2002) A novel biology-based approach in radiotherapy. Lancet Oncol. 3: 728-737
155. Zerez C. R., Roth E. F. Jr, Schulman S. and Tanaka K. R. (1990) Increased nicotinamide adenine dinucleotide content and synthesis in Plasmodium falciparum-infected human erythrocytes. Blood 75: 1705-1710
156. Preiss J. and Handler P. (1957) Enzymatic synthesis of nicotinamide mononucleotide. J. Biol. Chem. 225: 759-770
157. Elliott G. C., Ajioka J. and Okada C. Y. (1980) A rapid procedure for assaying nicotinamide phosphoribosyltransferase. Anal. Biochem. 107: 199-205
158. Berger S. J. and Berger N. A. (1986) An enzymatic method for the measurement of nicotinamide mononucleotide pyrophosphorylase in cells and tissues. Anal. Biochem. 154: 64-70
159. Berger S. J., Manory I., Sudar D. C., Krothapalli D. and Berger N. A. (1987) Pyridine nucleotide analog interference with metabolic processes in mitogen-stimulated human T lymphocytes. Exp. Cell Res. 173: 379-387
160. Rocchigiani M., Micheli V., Duley J. A. and Simmonds H. A. (1992) Determination of nicotinamide phosphoribosyltransferase activity in human erythrocytes: high-performance liquid chromatography-linked method. Anal. Biochem. 205: 334-336
161. Micheli V., Simmonds H. A., Sestini S. and Ricci C. (1990) Importance of nicotinamide as an NAD precursor in the human erythrocyte. Arch. Biochem. Biophys. 283: 40-45
162. Micheli V., Sestini S., Rocchigiani M., Pescaglini M. and Ricci C. (1987) Nucleotide synthesis in human erythrocyte: correlations between purines and pyridines. Biomed. Biochim. Acta. 46: S268-272
163. Samal B., Sun Y., Stearns G., Xie C., Suggs S. and McNiece I. (1994) Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol. Cell. Biol. 14: 1431-1437
164. Rongvaux A., Shea R. J., Mulks M. H., Gigot D., Urbain J., Leo O. et al. (2002) Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis. Eur. J. Immunol. 32: 3225-3234
165. Preiss J. and Handler P. (1958) Biosynthesis of diphosphopyridine nucleotide. J. Biol. Chem. 233: 493-500
166. Niedel J. and Dietrich L. S. (1973) Nicotinate phosphoribosyltransferase of human erythrocytes. Purification and properties. J. Biol. Chem. 248: 3500-3505
167. Vinitsky A. and Grubmeyer C. (1993) A new paradigm for biochemical energy coupling. Salmonella typhimurium nicotinate phosphoribosyltransferase. J. Biol. Chem. 268: 26004-26010
168. Sestini S., Jacomelli G., Pescaglini M., Micheli V. and Pompucci G. (2000) Enzyme activities leading to NAD synthesis in human lymphocytes. Arch. Biochem. Biophys. 379: 277-282
169. Schmidt-Brauns J., Herbert M., Kemmer G., Kraiss A., Schlor S. and Reidl J. (2001) Is a NAD pyrophosphatase activity necessary for Haemophilus influenzae type b multiplication in the blood stream? Int. J. Med. Microbiol. 291: 219-225
170. Hillyard D., Rechsteiner M., Manlapaz-Ramos P., Imperial J. S., Cruz L. J. and Olivera B. M. (1981) The pyridine nucleotide cycle. Studies in Escherichia coli and the human cell line D98/AH2. J. Biol. Chem. 256: 8491-8497
171. Sasiak K. and Saunders P. P. (1996) Purification and properties of a human nicotinamide ribonucleoside kinase. Arch. Biochem. Biophys. 333: 414-418
172. Grossman L. and Kaplan N. O. (1958) Nicotinamide riboside phosphorylase from human erythrocytes. J. Biol. Chem. 231: 717-726
173. White H. B. III (1981) Biosynthetic and salvage pathways of pyridine nucleotide coenzymes. In: The Pyridine Nucleotide Coenzymes, pp. 225-248, Everse J., Anderson B., You K. S. (eds), Academic Press, New York
174. Moat G. A. and Foster J. W. (1986) Biosynthesis and salvage pathways of pyridine nucleotides. In: Pyridine Nucleotide Coenzymes, Part B, pp. 1-24, Dolphin D., Poulson R., Avramovic O. (eds), Wiley-Interscience, New York
175. Yang J., Klaidman L. K., Nalbandian A., Oliver J., Chang M. L., Chan P. H. et al. (2002) The effects of nicotinamide on energy metabolism following transient focal cerebral ischemia in Wistar rats. Neurosci. Lett. 333: 91-94